Molecular profiling of Asian patients with advanced melanoma receiving check-point inhibitor treatment.

Abstract excerpt

OBJECTIVE: Melanoma is major medical challenge and being able to monitor treatment response is critical. This study aimed to use molecular profiling of Asian patients with advanced melanoma who were receiving treatment with check-point inhibitors (CPIs) to identify novel biomarkers of tumor response. METHODS: Next-generation sequencing (NGS) was performed using tumor specimens collected from 178 Asian patients...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to High-Throughput Nucleotide Sequencing
• Share to Melanoma
• Share to Mutation